ExodusPoint Capital Management, LP
Position in BSX — Boston Scientific Corp
CIK 1736225
NEW YORK, NY
Position in BSX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$19,538,028
+$3,099,688 QoQ
Shares Held
311,363
+80.6% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Derivatives in BSX
reported options exposure · as of Mar 31, 2026CallValue
$1,568,750
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Mar 31, 2026ExodusPoint Capital Management, LP holds $345,630,527 across 29 Medical Devices names. BSX ranks #4 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
465,215 | $152,762,649 | |
| 2 | LIVN |
LivaNova PLC
|
495,618 | $31,501,480 | |
| 3 | DXCM |
Dexcom Inc
|
317,067 | $19,911,807 | |
| 4 | BSX |
Boston Scientific Corp
This page
|
311,363 | $19,538,028 | |
| 5 | GKOS |
GLAUKOS Corp
|
179,728 | $19,349,516 | |
| 6 | GMED |
Globus Medical Inc
|
208,902 | $17,998,996 | |
| 7 | EW |
Edwards Lifesciences Corp
|
215,124 | $17,227,129 | |
| 8 | TNDM |
Tandem Diabetes Care Inc
|
632,899 | $12,132,673 |
All Filings in BSX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,568,750 | 25,000 | Call | Sole | 2026-05-14 | |
| 2026-03-31 | $19,538,028 | 311,363 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,438,340 | 172,400 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,784,719 | 202,650 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $81,187,674 | 755,867 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $56,620,413 | 561,265 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $27,096,472 | 303,364 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $84,095,311 | 1,003,524 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $52,343,157 | 679,693 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $15,602,638 | 227,809 | Shares | Sole | 2024-05-14 | |
| 2023-06-30 | $19,606,759 | 362,484 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $8,043,573 | 160,775 | Shares | Sole | 2023-05-11 | |
| 2022-06-30 | $3,439,834 | 92,295 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $7,994,655 | 180,507 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $3,881,525 | 91,373 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,125,487 | 118,126 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $2,628,756 | 61,477 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $5,159,659 | 133,497 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $8,788,804 | 244,473 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $4,137,845 | 115,100 | Call | Sole | 2021-02-16 | |
| 2020-09-30 | $638,832 | 16,719 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $4,859,575 | 138,410 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,886,428 | 119,106 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||